Skip to main content
Premium Trial:

Request an Annual Quote

ABI Balks, and SurroMed Taps Callida to Share $7.6M Grant to Build HTP Genotyping System

NEW YORK, Oct. 1 - SurroMed and Callida Genomics will share a $7.6 million grant from the US government to develop a universal high-throughput genotyping system.


The partners said the money, awarded by the National Institute of Standards and Technology's Advanced Technology Program, will help them develop a system that can score more than 100,000 SNPs per patient using a solution-array approach.


Over the next three years, SurroMed, which will receive $4.4 million, will bring to the table its Nanobarcode particle technology. Hyseq subsidiary Callida, which will pocket $3.2 million, will amplify DNA and identify and read SNPs, the companies said. NIST awards require each company to match its portion.


A SurroMed spokesman said the award, in October 2001, was originally slated to go to his company and Applied Biosystems. But ABI balked out, leaving SurroMed scrambling for a new partner. "We identified Callida, and here we are," said the spokesman, August Moretti.


Click here for more information.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.